five

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

收藏
NIAID Data Ecosystem2026-03-06 收录
下载链接:
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2028571
下载链接
链接失效反馈
官方服务:
资源简介:
The purpose of this study is to determine the objective response rate of patients with previously untreated metastatic colorectal cancer treated with the combination of cetuximab, capecitabine, and oxaliplatin with out without bevacizumab.
创建时间:
2006-04-15
二维码
社区交流群
二维码
科研交流群
商业服务